Form 4: Kiromic Biopharma Director Pamela Misajon Receives Restricted Stock Award

Director Pamela Misajon of Kiromic Biopharma, Inc. was granted 18,000 shares of restricted stock on March 18, 2024.

Summary

• Pamela Misajon, a director at Kiromic Biopharma, Inc., received a restricted stock award on March 18, 2024.
• The award consists of 18,000 shares of Kiromic Biopharma's stock.
• Following the transaction, Ms. Misajon beneficially owns 25,500 shares.
• The restricted stock vests on the one-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction disclosure. The grant of stock can be seen as a positive, but it's a routine event.

Positives

• The grant of restricted stock aligns the director's interests with those of the shareholders.
• Increased share ownership by a director can be seen as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The stock award aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Kiromic Biopharma, KRBP, Pamela Misajon, restricted stock award, Form 4, beneficial ownership, director